Previously, ECM1 was found to influence various epithelial malignancies’ progression through the modulation of cellular proliferative activity (Wang et al., 2019), tumor metastasis (Wu et al., 2019) and drug resistance (Lee et al., 2014; Lee and Lee, 2022; Lv et al., 2022). Here, ECM1 is linked to neoplasm.